Travere Therapeutics (TVTX) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to $3.0 million.
- Travere Therapeutics' Interest & Investment Income fell 1464.99% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year decrease of 3424.01%. This contributed to the annual value of $17.8 million for FY2024, which is 1815.05% down from last year.
- According to the latest figures from Q3 2025, Travere Therapeutics' Interest & Investment Income is $3.0 million, which was down 1464.99% from $3.3 million recorded in Q2 2025.
- Travere Therapeutics' 5-year Interest & Investment Income high stood at $14.4 million for Q4 2022, and its period low was -$5.3 million during Q1 2021.
- For the 5-year period, Travere Therapeutics' Interest & Investment Income averaged around $1.9 million, with its median value being $3.6 million (2024).
- In the last 5 years, Travere Therapeutics' Interest & Investment Income surged by 41305.86% in 2022 and then crashed by 5044.35% in 2023.
- Travere Therapeutics' Interest & Investment Income (Quarter) stood at -$4.6 million in 2021, then surged by 413.06% to $14.4 million in 2022, then tumbled by 50.44% to $7.2 million in 2023, then plummeted by 46.94% to $3.8 million in 2024, then dropped by 19.71% to $3.0 million in 2025.
- Its last three reported values are $3.0 million in Q3 2025, $3.3 million for Q2 2025, and $3.8 million during Q1 2025.